“The revision of the outlook to stable is due largely to CHS’ recent pattern of weaker earnings,” said S&P analyst Margaret McNamara.
The rating affirmation reflects S&P’s view of CHS’ improving balance sheet and leading market position.
More articles on healthcare finance:
Fitch affirms MultiCare Health System’s ‘AA-‘ rating
Moody’s affirms Summit Health’s ‘A2’ rating
Moody’s revises Mercy Hospital’s outlook to negative
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
